 |
|
Parkinson Disease With Old-Age Onset
A Comparative Study With Subjects With Middle-Age Onset
Nico J. Diederich, MD;
Charity G. Moore, MSPH, PhD;
Sue E. Leurgans, PhD;
Teresa A. Chmura, BS;
Christopher G. Goetz, MD
Arch Neurol. 2003;60:529-533.
Background To our knowledge, no prior study has focused on subjects with Parkinson disease (PD) with elderly disease onset, and there is little evidence-based knowledge of treatment outcomes in these patients.
Objective To compare the clinical presentation, comorbidities, treatment, and evolution of PD in patients with old-age onset with those of patients with middle-age onset in one US university center.
Design In the Rush Movement Disorder Database, we retrieved 43 patients with PD with onset at 78 years or older. By using a case-control design, we assigned each patient with old-age PD onset 1 (n = 5) or 2 (n = 38) patients with middle-age PD onset, matched for disease duration but with disease onset between the ages of 43 and 66 years. We compared the groups on several clinical measures using conditional logistic regression.
Results At a comparable length of PD duration (mean, 5.1 years for patients with old-age PD onset and 5.5 years for patients with middle-age PD onset), the total Unified Parkinson's Disease Rating Scale motor score was significantly higher in those with old-age PD onset than in those with middle-age PD onset (33.3 vs 21.2; P<.001). The patients with old-age onset had higher scores for rigidity (5.2 vs 4.3; P = .03), bradykinesia (13.0 vs 9.6; P = .001), and axial impairment (12.8 vs 5.2; P<.001), but not for tremor (2.2 vs 2.0; P = .68). They were more likely to have at least one comorbid condition compared with patients with middle-age onset (24 [56%] of 43 patients vs 20 [25%] of 81 patients; P = .002), but even when adjusting for comorbidities, they still maintained higher motor scores than controls. When treating patients with old-age PD onset, clinicians used levodopa monotherapy more frequently than in patients with middle-age PD onset (34 patients [79%] vs 16 patients [20%]; P<.001), and agonists were prescribed less frequently (5 patients [12%] vs 29 patients [36%]; P = .005).
Conclusions At the same disease duration, patients with old-age PD onset have greater motor impairment than patients with middle-age PD onset. This difference may be due to more rapid disease progression, less aggressive or less potent medical treatment, the elderly age of the subjects with old-age PD onset at study end independent of disease onset, or yet-to-be elucidated influences of comorbid conditions. Focused research on old-age PD onset is important to delineate the confounding influences of aging and comorbidities and to establish the safety and efficacy of new treatments for this group of patients.
From the Department of Neuroscience, Centre Hospitalier de Luxembourg, Luxembourg (Dr Diederich); the Departments of Neurology (Drs Diederich, Moore, Leurgans, and Goetz and Ms Chmura) and Preventive Medicine (Drs Moore and Leurgans), Rush-Presbyterian-St Luke's Medical Center, Chicago, Ill; and the Department of Epidemiology and Biostatistics, Norman J. Arnold School of Public Health, University of South Carolina, Columbia (Dr Moore).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Parkinson disease and risk of mortality: A prospective comorbidity-matched cohort study
Driver et al.
Neurology 2008;70:1423-1430.
ABSTRACT
| FULL TEXT
The Relationship of Parkinson Disease With Aging
Levy
Arch Neurol 2007;64:1242-1246.
ABSTRACT
| FULL TEXT
Practice Parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
Suchowersky et al.
Neurology 2006;66:968-975.
ABSTRACT
| FULL TEXT
Progression of motor impairment and disability in Parkinson disease: A population-based study
Alves et al.
Neurology 2005;65:1436-1441.
ABSTRACT
| FULL TEXT
Contribution of Aging to the Severity of Different Motor Signs in Parkinson Disease
Levy et al.
Arch Neurol 2005;62:467-472.
ABSTRACT
| FULL TEXT
Parkinson Disease With Old-Age Onset
Jellinger
Arch Neurol 2003;60:1814-1815.
FULL TEXT
Clinical Characteristics of Late-Onset Parkinson Disease
Papapetropoulos et al.
Arch Neurol 2003;60:1815-1816.
FULL TEXT
Practice Parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
Suchowersky et al.
Neurology 2006;66:968-975.
ABSTRACT
| FULL TEXT
|
